$MMATQ
META MATERIALS INC.

2023 Q1 Form 10-K Financial Statement

#000095017023009314 Filed on March 23, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2022
Revenue $1.412M $1.446M $10.20M
YoY Change -52.52% -36.85% 149.85%
Cost Of Revenue $741.0K $682.8K $3.036M
YoY Change -4.85% 28.89% 349.16%
Gross Profit $671.3K $762.9K $7.164M
YoY Change -69.43% -56.64% 110.3%
Gross Profit Margin 47.53% 52.77% 70.23%
Selling, General & Admin $12.71M $18.85M $67.79M
YoY Change -18.7% 28.89% 112.06%
% of Gross Profit 1893.55% 2471.17% 946.24%
Research & Development $6.519M $5.947M $22.64M
YoY Change 64.17% 39.33% 138.39%
% of Gross Profit 971.2% 779.45% 316.03%
Depreciation & Amortization $1.500M $3.895M $3.600M
YoY Change 98.69% 130.06% 100.0%
% of Gross Profit 223.45% 510.48% 50.25%
Operating Expenses $19.23M $24.80M $90.43M
YoY Change -1.91% 31.25% 118.09%
Operating Profit -$18.56M -$24.04M -$83.26M
YoY Change 6.61% 40.27% 118.78%
Interest Expense $113.0K $1.259M $174.2K
YoY Change -31.28% 128.05% -84.25%
% of Operating Profit
Other Income/Expense, Net -$406.2K -$2.109M -$1.672M
YoY Change -60.39% -84.5% -96.89%
Pretax Income -$18.97M -$20.90M -$84.94M
YoY Change 2.88% -30.8% -7.53%
Income Tax -$296.7K -$5.687M -$5.834M
% Of Pretax Income
Net Earnings -$18.70M -$15.21M -$79.10M
YoY Change 1.44% -48.49% -13.07%
Net Earnings / Revenue -1324.12% -1052.04% -775.48%
Basic Earnings Per Share -$0.05 -$0.24
Diluted Earnings Per Share -$0.05 -$0.04 -$0.24
COMMON SHARES
Basic Shares Outstanding 382.2M 361.9M 328.4M
Diluted Shares Outstanding 368.9M 328.4M

Balance Sheet

Concept 2023 Q1 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $6.033M $10.09M $10.09M
YoY Change -79.72% -79.62% -79.62%
Cash & Equivalents $6.033M $10.09M
Short-Term Investments $0.00 $0.00
Other Short-Term Assets $339.5K $365.6K $8.931M
YoY Change -99.56% -46.48% -88.8%
Inventory $459.6K $468.0K $468.0K
Prepaid Expenses $3.066M $2.836M
Receivables $837.8K $902.7K $902.7K
Other Receivables $621.2K $2.212M $2.212M
Total Short-Term Assets $16.48M $22.60M $22.60M
YoY Change -84.88% -82.79% -82.79%
LONG-TERM ASSETS
Property, Plant & Equipment $43.67M $42.67M $48.25M
YoY Change 45.67% 57.95% 44.91%
Goodwill $281.9M $281.7M
YoY Change 17.1% 17.21%
Intangibles $54.89M $56.31M
YoY Change 93.93% 94.37%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $385.9M $386.3M $386.3M
YoY Change 26.4% 27.65% 27.65%
TOTAL ASSETS
Total Short-Term Assets $16.48M $22.60M $22.60M
Total Long-Term Assets $385.9M $386.3M $386.3M
Total Assets $402.4M $408.9M $408.9M
YoY Change -2.88% -5.78% -5.78%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $15.77M $16.69M $16.69M
YoY Change 58.58% 25.19% 25.19%
Accrued Expenses $986.8K $967.1K $967.1K
YoY Change 26.05% 45.68% 45.68%
Deferred Revenue $731.0K $730.5K
YoY Change 5.15% -6.31%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $655.5K $483.2K $483.2K
YoY Change 80.25% -1.64% -1.64%
Total Short-Term Liabilities $18.95M $19.67M $19.67M
YoY Change -77.62% -78.53% -78.53%
LONG-TERM LIABILITIES
Long-Term Debt $3.129M $3.071M $3.251M
YoY Change 7.13% 12.19% 8.16%
Other Long-Term Liabilities $4.109M $4.174M $4.174M
YoY Change -5.25% -3.98% -3.98%
Total Long-Term Liabilities $3.129M $3.071M $7.425M
YoY Change 7.13% 12.19% 0.98%
TOTAL LIABILITIES
Total Short-Term Liabilities $18.95M $19.67M $19.67M
Total Long-Term Liabilities $3.129M $3.071M $7.425M
Total Liabilities $29.40M $30.35M $30.35M
YoY Change -68.23% -69.44% -69.44%
SHAREHOLDERS EQUITY
Retained Earnings -$226.2M -$207.5M
YoY Change 54.06% 61.61%
Common Stock $604.1M $591.3M
YoY Change 29.08% 27.6%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $373.0M $378.6M $378.6M
YoY Change
Total Liabilities & Shareholders Equity $402.4M $408.9M $408.9M
YoY Change -2.88% -5.78% -5.78%

Cashflow Statement

Concept 2023 Q1 2022 Q4 2022
OPERATING ACTIVITIES
Net Income -$18.70M -$15.21M -$79.10M
YoY Change 1.44% -48.49% -13.07%
Depreciation, Depletion And Amortization $1.500M $3.895M $3.600M
YoY Change 98.69% 130.06% 100.0%
Cash From Operating Activities -$15.52M -$13.73M -$62.24M
YoY Change -17.2% -28.43% 79.04%
INVESTING ACTIVITIES
Capital Expenditures $1.694M $7.612M $19.59M
YoY Change -196.96% -218.97% -253.16%
Acquisitions $3.487M
YoY Change -94.73%
Other Investing Activities $1.256M $1.943M $115.3K
YoY Change -56.46% -102.81% -99.85%
Cash From Investing Activities -$437.5K -$5.670M -$19.47M
YoY Change -138.44% -92.48% -129.89%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $85.46K $552.6K
YoY Change -6.75% -49.31%
Cash From Financing Activities 10.66M 8.080K 46.37M
YoY Change 3776.42% -98.98% 196.16%
NET CHANGE
Cash From Operating Activities -15.52M -13.73M -62.24M
Cash From Investing Activities -437.5K -5.670M -19.47M
Cash From Financing Activities 10.66M 8.080K 46.37M
Net Change In Cash -5.294M -19.39M -35.35M
YoY Change -69.46% -79.33% -176.79%
FREE CASH FLOW
Cash From Operating Activities -$15.52M -$13.73M -$62.24M
Capital Expenditures $1.694M $7.612M $19.59M
Free Cash Flow -$17.21M -$21.34M -$81.83M
YoY Change 1.27% 66.95% 272.38%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q2 mmat Warrant Expiration Term
WarrantExpirationTerm
P5Y6M
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001431959
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
001-36247
CY2022 dei Entity Registrant Name
EntityRegistrantName
Meta Materials Inc.
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
74-3237581
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
60 Highfield Park Drive
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Dartmouth
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
NS
CY2022 dei Entity Address Country
EntityAddressCountry
CA
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
B3A 4R9
CY2022 dei City Area Code
CityAreaCode
902
CY2022 dei Local Phone Number
LocalPhoneNumber
482-5729
CY2022 dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
CY2022 dei Trading Symbol
TradingSymbol
MMAT
CY2022 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Public Float
EntityPublicFloat
371634314
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
382152643
CY2022 dei Auditor Name
AuditorName
KPMG LLP
CY2022 dei Auditor Location
AuditorLocation
Vaughan, ON, Canada
CY2022 dei Auditor Firm
AuditorFirmId
85
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10090858
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
46645704
CY2022Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
1720613
CY2021Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
788768
CY2021Q4 us-gaap Short Term Investments
ShortTermInvestments
2875638
CY2021Q4 us-gaap Grants Receivable Current
GrantsReceivableCurrent
175780
CY2022Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
902718
CY2021Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
1665700
CY2022Q4 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
2211900
CY2022Q4 us-gaap Inventory Net
InventoryNet
468027
CY2021Q4 us-gaap Inventory Net
InventoryNet
265718
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7202099
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3451367
CY2021Q4 us-gaap Assets Held For Sale Not Part Of Disposal Group Current
AssetsHeldForSaleNotPartOfDisposalGroupCurrent
75500000
CY2022Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
8461
CY2021Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
10657
CY2022Q4 us-gaap Assets Current
AssetsCurrent
22604676
CY2021Q4 us-gaap Assets Current
AssetsCurrent
131379332
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
56313317
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
28971824
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
42674699
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
27018114
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
5576824
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
6278547
CY2022Q4 us-gaap Goodwill
Goodwill
281748466
CY2021Q4 us-gaap Goodwill
Goodwill
240376634
CY2022Q4 us-gaap Assets
Assets
408917982
CY2021Q4 us-gaap Assets
Assets
434024451
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
16694211
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
13335470
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
483226
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
491278
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
730501
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
779732
CY2022Q4 mmat Deferred Government Assistance Current
DeferredGovernmentAssistanceCurrent
799490
CY2021Q4 mmat Deferred Government Assistance Current
DeferredGovernmentAssistanceCurrent
846612
CY2021Q4 mmat Preferred Stock Dividends Payable Current
PreferredStockDividendsPayableCurrent
75500000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
967126
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
663861
CY2021Q4 us-gaap Asset Retirement Obligation Current
AssetRetirementObligationCurrent
21937
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
19674554
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
91638890
CY2022Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
479808
CY2021Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
637008
CY2022Q4 mmat Deferred Government Assistance Amount Noncurrent
DeferredGovernmentAssistanceAmountNoncurrent
319017
CY2021Q4 mmat Deferred Government Assistance Amount Noncurrent
DeferredGovernmentAssistanceAmountNoncurrent
3038
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
3253985
CY2021Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
324479
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3375031
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3706774
CY2022Q4 us-gaap Contractual Obligation
ContractualObligation
180705
CY2021Q4 us-gaap Contractual Obligation
ContractualObligation
268976
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
3070729
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2737171
CY2022Q4 us-gaap Liabilities
Liabilities
30353829
CY2021Q4 us-gaap Liabilities
Liabilities
99316336
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
362247867
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
362247867
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
284573316
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
284573316
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
340425
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
262751
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
590962866
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
463136404
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-5242810
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-296936
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-207496328
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-128394104
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
378564153
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
334708115
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
408917982
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
434024451
CY2022 us-gaap Revenues
Revenues
10200167
CY2021 us-gaap Revenues
Revenues
4082517
CY2022 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3036190
CY2021 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
675973
CY2022 us-gaap Gross Profit
GrossProfit
7163977
CY2021 us-gaap Gross Profit
GrossProfit
3406544
CY2022 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
6244883
CY2021 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2267354
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
61543282
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
29699601
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
22640495
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9497427
CY2022 us-gaap Operating Expenses
OperatingExpenses
90428660
CY2021 us-gaap Operating Expenses
OperatingExpenses
41464382
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-83264683
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-38057838
CY2022 us-gaap Interest Expense
InterestExpense
174234
CY2021 us-gaap Interest Expense
InterestExpense
1106445
CY2022 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-2054447
CY2021 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-205882
CY2022 mmat Gain Loss On Deconsolidation Of Wholly Owned Subsidiary
GainLossOnDeconsolidationOfWhollyOwnedSubsidiary
3990737
CY2021 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-40540091
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3433757
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-11939068
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1671701
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-53791486
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-84936384
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-91849324
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-5834160
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-852063
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-79102224
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-90997261
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-4945874
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-321663
CY2021 us-gaap Other Comprehensive Income Loss Financial Liability Fair Value Option After Tax And Reclassification Adjustment
OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionAfterTaxAndReclassificationAdjustment
680611
CY2022 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-4945874
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
358948
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-84048098
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-90638313
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.24
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.24
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.39
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.39
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
328350452
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
328350452
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
232898398
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
232898398
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-8897403
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-90997261
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
358948
CY2021 mmat Stock Issued During Period Value Conversion Of Commercial Paper
StockIssuedDuringPeriodValueConversionOfCommercialPaper
23656365
CY2021 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
22118782
CY2021 mmat Stock Issued During Period Value Conversion Of Unsecured Debentures
StockIssuedDuringPeriodValueConversionOfUnsecuredDebentures
5769475
CY2021 mmat Stock Issued During Period Value Conversion Of Long Term Debt
StockIssuedDuringPeriodValueConversionOfLongTermDebt
221843
CY2021 mmat Stock Issued During Period Value Conversion Of Due To Related Party
StockIssuedDuringPeriodValueConversionOfDueToRelatedParty
225986
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1293263
CY2021 mmat Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
122470
CY2021 mmat Stock Issued During Period Value Broker Warrants Exercised
StockIssuedDuringPeriodValueBrokerWarrantsExercised
16256
CY2021 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
369461410
CY2021 mmat Stock Issued During Period Value Issued In Lieu Of Operating Lease Liability
StockIssuedDuringPeriodValueIssuedInLieuOfOperatingLeaseLiability
2781968
CY2021 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
8576013
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
334708115
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-79102224
CY2022 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-4945874
CY2022 mmat Issuance Of Common Stock And Warrants Value
IssuanceOfCommonStockAndWarrantsValue
50000000
CY2022 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
3680666
CY2022 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
448711
CY2022 mmat Stock Issued During Period Value Settlement Of Restricted Stock Units
StockIssuedDuringPeriodValueSettlementOfRestrictedStockUnits
18027
CY2022 mmat Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
169574
CY2022 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
67122513
CY2022 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
223052
CY2022 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
13862031
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
378564153
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-79102224
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-90997261
CY2022 mmat Noncash Finance Income
NoncashFinanceIncome
135524
CY2021 mmat Noncash Finance Income
NoncashFinanceIncome
471689
CY2022 us-gaap Paid In Kind Interest
PaidInKindInterest
403317
CY2021 us-gaap Paid In Kind Interest
PaidInKindInterest
902940
CY2022 mmat Non Cash Lease Expense
NonCashLeaseExpense
1608992
CY2021 mmat Non Cash Lease Expense
NonCashLeaseExpense
439791
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-5834160
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-852063
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
9272074
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
3491493
CY2022 us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
-108004
CY2021 us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
-237013
CY2022 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-2050029
CY2021 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-407352
CY2021 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-40540091
CY2022 mmat Gain Loss On Deconsolidation Of Wholly Owned Subsidiary
GainLossOnDeconsolidationOfWhollyOwnedSubsidiary
3990737
CY2022 mmat Adjustments In Contract With Customer Liability
AdjustmentsInContractWithCustomerLiability
-129679
CY2021 mmat Adjustments In Contract With Customer Liability
AdjustmentsInContractWithCustomerLiability
-679541
CY2022 mmat Government Assistance
GovernmentAssistance
3047
CY2021 mmat Government Assistance
GovernmentAssistance
544932
CY2022 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
783
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-19253
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
13184396
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
1576849
CY2022 mmat Non Cash Consulting Expense
NonCashConsultingExpense
677638
CY2021 mmat Non Cash Consulting Expense
NonCashConsultingExpense
6513378
CY2022 us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
353090
CY2021 us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
-4652415
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-62244794
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-34764911
CY2021 mmat Payments For Proceeds From Intangible Assets
PaymentsForProceedsFromIntangibleAssets
1133894
CY2022 mmat Payments For Proceeds From Property And Equipment
PaymentsForProceedsFromPropertyAndEquipment
19587511
CY2021 mmat Payments For Proceeds From Property And Equipment
PaymentsForProceedsFromPropertyAndEquipment
11655417
CY2022 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
39140
CY2022 us-gaap Payments For Proceeds From Short Term Investments
PaymentsForProceedsFromShortTermInvestments
-2811152
CY2021 us-gaap Payments For Proceeds From Short Term Investments
PaymentsForProceedsFromShortTermInvestments
2889852
CY2022 mmat Proceeds From Below Market Capital Government Loan
ProceedsFromBelowMarketCapitalGovernmentLoan
1071862
CY2022 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
3486906
CY2021 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
66131025
CY2022 mmat Loan Advance Pursuant To Deconsolidation
LoanAdvancePursuantToDeconsolidation
319987
CY2021 us-gaap Cash Acquired In Excess Of Payments To Acquire Business
CashAcquiredInExcessOfPaymentsToAcquireBusiness
146954733
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-19472250
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
65144545
CY2021 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
1127151
CY2022 mmat Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
50000000
CY2022 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
3680666
CY2022 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
552579
CY2021 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1090047
CY2021 mmat Proceeds From Government Grants
ProceedsFromGovernmentGrants
223384
CY2021 us-gaap Proceeds From Issuance Of Commercial Paper
ProceedsFromIssuanceOfCommercialPaper
13963386
CY2022 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
448711
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1293263
CY2022 mmat Repurchases Of Common Stock For Income Tax Withheld Upon Settlement Of Restricted Stock Units
RepurchasesOfCommonStockForIncomeTaxWithheldUponSettlementOfRestrictedStockUnits
18027
CY2022 mmat Proceeds From Broker Warrants Exercises
ProceedsFromBrokerWarrantsExercises
169574
CY2021 mmat Proceeds From Broker Warrants Exercises
ProceedsFromBrokerWarrantsExercises
138726
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
46367013
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
15655863
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-35350031
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
46035497
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
47434472
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1395683
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-272970
CY2021 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3292
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11811471
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
47434472
CY2022 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
2270887
CY2021 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1692969
CY2022 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
288499
CY2021 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
3590148
CY2021 mmat Right Of Use Assets And Prepaid Expenses Recognized In Exchange For Common Stock
RightOfUseAssetsAndPrepaidExpensesRecognizedInExchangeForCommonStock
2149381
CY2021 us-gaap Stock Issued1
StockIssued1
51992451
CY2021 us-gaap Interest Paid Net
InterestPaidNet
64528
CY2022 us-gaap Substantial Doubt About Going Concern Managements Evaluation
SubstantialDoubtAboutGoingConcernManagementsEvaluation
Our evaluation entails analyzing prospective operating budgets and forecasts for expectations of our cash needs and comparing those needs to the current cash and cash equivalent balances.
CY2022 us-gaap Substantial Doubt About Going Concern Within One Year
SubstantialDoubtAboutGoingConcernWithinOneYear
true
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-79100000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-91000000.0
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-207500000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Use of estimates </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">–</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The preparation of these consolidated financial statements in conformity with US GAAP requires management to make estimates and certain assumptions that affect the amounts reported in these consolidated financial statements and accompanying notes. Actual results could differ from these estimates. Significant items subject to such estimates and assumptions include the valuation of goodwill, the valuation of net assets acquired via business combinations, and the preparation of the consolidated financial statements on a going concern basis.</span></p>
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0
CY2021 mmat Gain Loss On Common Shares And Liabilities Carrying Value Differences
GainLossOnCommonSharesAndLiabilitiesCarryingValueDifferences
19330
CY2021Q4 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P5Y
CY2022 us-gaap Revenue Recognition Deferred Revenue
RevenueRecognitionDeferredRevenue
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Deferred revenue </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">– Consist of fees invoiced or paid by our customers for which the associated performance obligations have not been satisfied and revenue has not been recognized based on our revenue recognition criteria described above.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Deferred revenue is reported in a net position on an individual contract basis at the end of each reporting period and is classified as current in the consolidated balance sheet when the revenue recognition associated with the related customer payments and invoicing is expected to occur within one year of the balance sheet date and as long-term when the revenue recognition associated with the related customer payments and invoicing is expected to occur more than one year from the balance sheet date.</span></p>
CY2021Q4 us-gaap Equity Fair Value Disclosure
EquityFairValueDisclosure
369461410
CY2021 us-gaap Liabilities Fair Value Adjustment
LiabilitiesFairValueAdjustment
-11322637
CY2021Q4 us-gaap Equity Issued In Business Combination Fair Value Disclosure
EquityIssuedInBusinessCombinationFairValueDisclosure
358138773
CY2021Q4 us-gaap Goodwill
Goodwill
240376634
CY2022Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
490077
CY2021Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
196868
CY2022Q4 us-gaap Inventory Supplies Net Of Reserves
InventorySuppliesNetOfReserves
11345
CY2021Q4 us-gaap Inventory Supplies Net Of Reserves
InventorySuppliesNetOfReserves
8886
CY2022Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
51589
CY2021Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
30636
CY2022Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
42058
CY2021Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
29328
CY2022Q4 mmat Inventory Provision
InventoryProvision
127042
CY2022Q4 us-gaap Inventory Net
InventoryNet
468027
CY2021Q4 us-gaap Inventory Net
InventoryNet
265718
CY2022Q4 mmat Inventory Rawmaterial Restricted
InventoryRawmaterialRestricted
400000
CY2021Q4 mmat Inventory Rawmaterial Restricted
InventoryRawmaterialRestricted
0
CY2021 mmat Raw Material Inventory To Research And Development Expense
RawMaterialInventoryToResearchAndDevelopmentExpense
200000
CY2022 mmat Inventory In Cost Of Goods Sold
InventoryInCostOfGoodsSold
800000
CY2021 mmat Inventory In Cost Of Goods Sold
InventoryInCostOfGoodsSold
200000
CY2022 mmat Inventory Write Down Related To Cost Of Good Sold
InventoryWriteDownRelatedToCostOfGoodSold
100000
CY2021 mmat Inventory Write Down Related To Cost Of Good Sold
InventoryWriteDownRelatedToCostOfGoodSold
0
CY2022 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
42343552
CY2022 us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
1446639
CY2022 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-2418359
CY2022Q4 us-gaap Goodwill
Goodwill
281748466
CY2022 us-gaap Number Of Reporting Units
NumberOfReportingUnits
1
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
3553955
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
2835660
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1262112
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
365583
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
683044
CY2022Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
4000856
CY2021Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
1506211
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7202099
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3451367
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
52954295
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
34127218
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
10279596
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
7109104
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
42674699
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
27018114
CY2022 us-gaap Depreciation
Depreciation
3600000
CY2021 us-gaap Depreciation
Depreciation
1800000
CY2022 us-gaap Asset Impairment Charges
AssetImpairmentCharges
100000
CY2021 us-gaap Asset Impairment Charges
AssetImpairmentCharges
300000
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
65811004
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
33157178
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
9497687
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
4185354
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
56313317
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
28971824
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
5700000
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1700000
CY2021Q4 us-gaap Long Term Debt
LongTermDebt
3228449
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
483226
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
491278
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
3070729
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2737171
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
24477507
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.33
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y4M9D
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
688952
CY2021 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
4486965
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.36
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
85901
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0.34
CY2021 mmat Share Based Compensation Arrangements By Share Based Payment Award Options Fair Value Of Deemed Issuance To Torchlight In Period Number
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsFairValueOfDeemedIssuanceToTorchlightInPeriodNumber
1500000
CY2021 mmat Share Based Compensation Arrangements By Share Based Payment Award Options Fair Value Of Deemed Issuance To Torchlight During Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsFairValueOfDeemedIssuanceToTorchlightDuringPeriodWeightedAverageExercisePrice
2.22
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
21404641
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.46
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y4M2D
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
56924556
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
14318993
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.41
CY2022 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1688538
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
0.27
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
440052
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
1.02
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
33595044
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.80
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P9Y3M21D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
17611251
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
24327577
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.71
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P8Y2M23D
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
14917424
CY2022Q4 mmat Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Outstanding
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesOutstanding
33595044
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
24327577
CY2021Q4 mmat Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Outstanding
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesOutstanding
21404641
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
13231030
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.81
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
6.27
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.81
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.84
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0256
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0073
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y2M8D
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P1Y
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-58490568
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-30552839
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-26445816
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-61296485
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-84936384
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-91849324
CY2022 us-gaap Current Federal State And Local Tax Expense Benefit
CurrentFederalStateAndLocalTaxExpenseBenefit
1256
CY2021 us-gaap Current Federal State And Local Tax Expense Benefit
CurrentFederalStateAndLocalTaxExpenseBenefit
800
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
1256
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
800
CY2022 us-gaap Deferred Federal State And Local Tax Expense Benefit
DeferredFederalStateAndLocalTaxExpenseBenefit
-4893000
CY2022 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-942416
CY2021 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-852863
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-5835416
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-852863
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-5834160
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-852063
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-17836641
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-19288357
CY2022 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-1428381
CY2021 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-1075114
CY2022 mmat Effective Income Tax Rate Reconciliation Capital Loss
EffectiveIncomeTaxRateReconciliationCapitalLoss
7192458
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
2289214
CY2021 mmat Effective Income Tax Rate Reconciliation Unrealized Losses On Liabilities
EffectiveIncomeTaxRateReconciliationUnrealizedLossesOnLiabilities
11752697
CY2022 mmat Effective Income Tax Rate Reconciliation Other Permanent Items
EffectiveIncomeTaxRateReconciliationOtherPermanentItems
-3750116
CY2021 mmat Effective Income Tax Rate Reconciliation Other Permanent Items
EffectiveIncomeTaxRateReconciliationOtherPermanentItems
-114799
CY2022 mmat Income Tax Reconciliation Foreign Currency And Other
IncomeTaxReconciliationForeignCurrencyAndOther
185860
CY2021 mmat Income Tax Reconciliation Foreign Currency And Other
IncomeTaxReconciliationForeignCurrencyAndOther
929664
CY2022 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
319137
CY2022 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-1484069
CY2021 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-4889797
CY2022 mmat Effective Income Tax Rate Reconciliation Provision To Return
EffectiveIncomeTaxRateReconciliationProvisionToReturn
1595074
CY2022 mmat Effective Income Tax Rate Reconciliation Deferred True Ups
EffectiveIncomeTaxRateReconciliationDeferredTrueUps
1525095
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
22870613
CY2021 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
9544429
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-5834160
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-852063
CY2022Q4 mmat Deferred Tax Asset Non Capital Losses
DeferredTaxAssetNonCapitalLosses
30527370
CY2022Q4 us-gaap Deferred Tax Assets Capital Loss Carryforwards
DeferredTaxAssetsCapitalLossCarryforwards
7228389
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
5718562
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
4609247
CY2022Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
2824760
CY2021Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
1972694
CY2022Q4 mmat Deferred Tax Assets Research And Development Expense Capitalization
DeferredTaxAssetsResearchAndDevelopmentExpenseCapitalization
2198314
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
1144703
CY2022Q4 mmat Deferred Tax Assets Right Of Use Asset
DeferredTaxAssetsRightOfUseAsset
808717
CY2022Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
72895
CY2021Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
69964
CY2022Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
37426
CY2021Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
46725
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
55170383
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
27199880
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
41688855
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
18659901
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
13481528
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
8539979
CY2022Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssets
12355386
CY2021Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssets
6276390
CY2022Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
2791147
CY2021Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
2226741
CY2022Q4 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
1234015
CY2022Q4 us-gaap Deferred Tax Liabilities Financing Arrangements
DeferredTaxLiabilitiesFinancingArrangements
189260
CY2021Q4 us-gaap Deferred Tax Liabilities Financing Arrangements
DeferredTaxLiabilitiesFinancingArrangements
251646
CY2022Q4 mmat Deferred Tax Liabilities Funding Obligation
DeferredTaxLiabilitiesFundingObligation
112974
CY2021Q4 mmat Deferred Tax Liabilities Funding Obligation
DeferredTaxLiabilitiesFundingObligation
109681
CY2022Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
52731
CY2022Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
16735513
CY2021Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
8864458
CY2022Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
3253985
CY2021Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
324479
CY2022Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
111400000
CY2021Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
91300000
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
55200000
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
27200000
CY2022 mmat Net Operating Loss Carry Forward Expiration Year Starting
NetOperatingLossCarryForwardExpirationYearStarting
2028
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
41700000
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
18700000
CY2022 mmat Net Loss
NetLoss
-79102224
CY2021 mmat Net Loss
NetLoss
-90997261
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
328350452
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
232898398
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
328350452
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
232898398
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.24
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.39
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.24
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.39
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
83933071
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
30630513
CY2022 mmat Increase Decrease In Grants Receivable
IncreaseDecreaseInGrantsReceivable
-172765
CY2021 mmat Increase Decrease In Grants Receivable
IncreaseDecreaseInGrantsReceivable
-149798
CY2022 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
319116
CY2021 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-325657
CY2022 us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
-287320
CY2021 us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
880613
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4799174
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2100370
CY2022 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
5410515
CY2021 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
6906375
CY2022 mmat Increase Decrease In Due From To Related Parties Current
IncreaseDecreaseInDueFromToRelatedPartiesCurrent
108102
CY2021 mmat Increase Decrease In Due From To Related Parties Current
IncreaseDecreaseInDueFromToRelatedPartiesCurrent
78940
CY2022 mmat Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
231
CY2021 mmat Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
-1018691
CY2022 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-997067
CY2021 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-688183
CY2022 us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
353090
CY2021 us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
-4652415
CY2022Q4 us-gaap Contractual Obligation
ContractualObligation
180705
CY2021Q4 us-gaap Contractual Obligation
ContractualObligation
268976
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
4342157
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
4370635
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
3553955
CY2021Q4 us-gaap Long Term Debt
LongTermDebt
3228449
CY2022 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
10200167
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4082517
CY2021Q4 mmat Development Contract Value
DevelopmentContractValue
41500000
CY2021 mmat Development Contract Period Maximum
DevelopmentContractPeriodMaximum
P5Y
CY2022Q4 mmat Development Contract Value
DevelopmentContractValue
4300000
CY2022Q4 us-gaap Deferred Revenue
DeferredRevenue
1210309
CY2021Q4 us-gaap Deferred Revenue
DeferredRevenue
1416740
CY2022Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
730501
CY2021Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
779732
CY2022Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
479808
CY2021Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
637008
CY2021Q4 us-gaap Grants Receivable Current
GrantsReceivableCurrent
175780
CY2022Q4 mmat Deferred Government Assistance
DeferredGovernmentAssistance
1118507
CY2021Q4 mmat Deferred Government Assistance
DeferredGovernmentAssistance
849650
CY2022Q4 mmat Deferred Government Assistance Current
DeferredGovernmentAssistanceCurrent
799490
CY2021Q4 mmat Deferred Government Assistance Current
DeferredGovernmentAssistanceCurrent
846612
CY2022Q4 mmat Deferred Government Assistance Non Current
DeferredGovernmentAssistanceNonCurrent
319017
CY2021Q4 mmat Deferred Government Assistance Non Current
DeferredGovernmentAssistanceNonCurrent
3038
CY2021 mmat Other Grants Income
OtherGrantsIncome
161990
CY2022 mmat Payroll Subsidies Income
PayrollSubsidiesIncome
77075
CY2021 mmat Payroll Subsidies Income
PayrollSubsidiesIncome
741322
CY2022 mmat Amortizations Of Deferred Government Assistance
AmortizationsOfDeferredGovernmentAssistance
3047
CY2021 mmat Amortizations Of Deferred Government Assistance
AmortizationsOfDeferredGovernmentAssistance
145739
CY2022 mmat Research And Development Tax Credit Amount
ResearchAndDevelopmentTaxCreditAmount
138410
CY2021 mmat Fair Value Gain On Recognition Of Loans
FairValueGainOnRecognitionOfLoans
236021
CY2021 mmat Deferred Government Assistance Income Recognized
DeferredGovernmentAssistanceIncomeRecognized
448894
CY2022 mmat Government Assistance Income Recognized
GovernmentAssistanceIncomeRecognized
218532
CY2021 mmat Government Assistance Income Recognized
GovernmentAssistanceIncomeRecognized
1733966
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-11939068
CY2022Q4 mmat Outstanding Funding Obligation
OutstandingFundingObligation
959835
CY2021Q4 mmat Outstanding Funding Obligation
OutstandingFundingObligation
1025398
CY2022Q4 mmat Fair Value Of Interest Free Component Of Funding Obligation
FairValueOfInterestFreeComponentOfFundingObligation
-852573
CY2022 mmat Non Cash Interest Accretion
NonCashInterestAccretion
403317
CY2021 mmat Non Cash Interest Accretion
NonCashInterestAccretion
904925
CY2022 mmat Interest Bank Charges
InterestBankCharges
-133518
CY2021 mmat Interest Bank Charges
InterestBankCharges
220460
CY2022 us-gaap Investment Income Interest
InvestmentIncomeInterest
95565
CY2021 us-gaap Investment Income Interest
InvestmentIncomeInterest
18940
CY2022 us-gaap Interest Expense
InterestExpense
174234
CY2021 us-gaap Interest Expense
InterestExpense
1106445
CY2021 mmat Loss Gain On Secured Convertible Debentures
LossGainOnSecuredConvertibleDebentures
-16957029
CY2021 mmat Gain Loss On Unsecured Convertible Debentures
GainLossOnUnsecuredConvertibleDebentures
-4076448
CY2021 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-40540091
CY2022 mmat Non Cash Losses From Remeasurement Of Fair Value Of Convertible Financial Liabilities
NonCashLossesFromRemeasurementOfFairValueOfConvertibleFinancialLiabilities
0
CY2021 mmat Non Cash Losses From Remeasurement Of Fair Value Of Convertible Financial Liabilities
NonCashLossesFromRemeasurementOfFairValueOfConvertibleFinancialLiabilities
0
CY2022 mmat Oil And Gas Assets Maintenance Cost
OilAndGasAssetsMaintenanceCost
3859851
CY2021 mmat Oil And Gas Assets Maintenance Cost
OilAndGasAssetsMaintenanceCost
14155851
CY2022 mmat Government Assistance Income Recognized
GovernmentAssistanceIncomeRecognized
218532
CY2021 mmat Government Assistance Income Recognized
GovernmentAssistanceIncomeRecognized
1733966
CY2022 mmat Other Income Nonoperating
OtherIncomeNonoperating
72038
CY2021 mmat Other Income Nonoperating
OtherIncomeNonoperating
8850
CY2022 mmat Fair Value Gain Loss On Long Term Debt
FairValueGainLossOnLongTermDebt
56185
CY2021 mmat Fair Value Gain Loss On Long Term Debt
FairValueGainLossOnLongTermDebt
2278
CY2022 mmat Fair Value Gain Loss On Funding Obligation
FairValueGainLossOnFundingObligation
79339
CY2021 mmat Fair Value Gain Loss On Funding Obligation
FairValueGainLossOnFundingObligation
471689
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3433757
CY2021Q4 mmat Fair Value Of Interest Free Component Of Funding Obligation
FairValueOfInterestFreeComponentOfFundingObligation
-855060
CY2022Q4 mmat Principal Adjusted For Interest Free Component Of Funding Obligation
PrincipalAdjustedForInterestFreeComponentOfFundingObligation
107262
CY2021Q4 mmat Principal Adjusted For Interest Free Component Of Funding Obligation
PrincipalAdjustedForInterestFreeComponentOfFundingObligation
170338
CY2022Q4 mmat Accumulated Non Cash Interest Accretion
AccumulatedNonCashInterestAccretion
73443
CY2021Q4 mmat Accumulated Non Cash Interest Accretion
AccumulatedNonCashInterestAccretion
98638
CY2022Q4 us-gaap Contractual Obligation
ContractualObligation
180705
CY2021Q4 us-gaap Contractual Obligation
ContractualObligation
268976
CY2022Q4 mmat Contractual Obligation Non Current
ContractualObligationNonCurrent
180705
CY2021Q4 mmat Contractual Obligation Non Current
ContractualObligationNonCurrent
268976
CY2019Q2 mmat Number Of Funding Tranches
NumberOfFundingTranches
2
CY2019Q2 mmat Number Of Milestones Achieved
NumberOfMilestonesAchieved
2
CY2019Q2 mmat Funds Repayment Commencement Period From Date Of Receipt
FundsRepaymentCommencementPeriodFromDateOfReceipt
P3Y
CY2019Q2 mmat Percentage Of Sales Revenue Used For Repayment Of Funds
PercentageOfSalesRevenueUsedForRepaymentOfFunds
0.10
CY2019Q2 mmat Proceeds From Funding Obligation Upon Achievement Of First Milestone
ProceedsFromFundingObligationUponAchievementOfFirstMilestone
325000
CY2019Q4 mmat Proceeds From Funding Obligation Upon Achievement Of Second Milestone
ProceedsFromFundingObligationUponAchievementOfSecondMilestone
975000
CY2019 mmat Funding Obligation Effective Interest Rate
FundingObligationEffectiveInterestRate
0.15
CY2021 mmat Funding Obligation Effective Interest Rate
FundingObligationEffectiveInterestRate
0.1917
CY2022 mmat Gain Loss On Funding Obligation
GainLossOnFundingObligation
79339
CY2021 mmat Gain Loss On Funding Obligation
GainLossOnFundingObligation
471004
CY2022 us-gaap Operating Lease Expense
OperatingLeaseExpense
2057157
CY2021 us-gaap Operating Lease Expense
OperatingLeaseExpense
546197
CY2022 us-gaap Short Term Lease Cost
ShortTermLeaseCost
584645
CY2021 us-gaap Short Term Lease Cost
ShortTermLeaseCost
229475
CY2022 mmat Variable And Other Lease Expense
VariableAndOtherLeaseExpense
263500
CY2021 mmat Variable And Other Lease Expense
VariableAndOtherLeaseExpense
92862
CY2022 us-gaap Lease Cost
LeaseCost
2905302
CY2021 us-gaap Lease Cost
LeaseCost
868534
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1261249
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1263455
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1153305
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
994967
CY2022Q4 mmat Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
2892472
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
7565448
CY2022Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
3223291
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
4342157
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
967126
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3375031
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.1717
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.1785
CY2022 mmat Number Of Patents
NumberOfPatents
6
CY2022 us-gaap Royalty Expense
RoyaltyExpense
0
CY2022Q3 us-gaap Land Subject To Ground Leases
LandSubjectToGroundLeases
11642
CY2022Q3 mmat Contractual Obligation Lease Term
ContractualObligationLeaseTerm
P132M
CY2022Q3 mmat Contractual Obligation Option To Renew Lease For Additional Term
ContractualObligationOptionToRenewLeaseForAdditionalTerm
P5Y
CY2022Q4 us-gaap Land Subject To Ground Leases
LandSubjectToGroundLeases
12655
CY2022Q4 mmat Contractual Obligation Option To Renew Lease For Additional Term
ContractualObligationOptionToRenewLeaseForAdditionalTerm
P5Y
CY2022Q4 mmat Annual Lease Payments Per Square Foot In Lease Year One
AnnualLeasePaymentsPerSquareFootInLeaseYearOne
18.00
CY2022Q4 mmat Annual Lease Payments Per Square Foot In Lease Year Two
AnnualLeasePaymentsPerSquareFootInLeaseYearTwo
18.50
CY2022Q4 mmat Annual Lease Payments Per Square Foot In Lease Year Three
AnnualLeasePaymentsPerSquareFootInLeaseYearThree
19.00
CY2022Q4 mmat Annual Lease Payments Per Square Foot In Lease Year Four
AnnualLeasePaymentsPerSquareFootInLeaseYearFour
19.50
CY2022Q4 mmat Annual Lease Payments Per Square Foot In Lease Year Five
AnnualLeasePaymentsPerSquareFootInLeaseYearFive
20.00

Files In Submission

Name View Source Status
0000950170-23-009314-index-headers.html Edgar Link pending
0000950170-23-009314-index.html Edgar Link pending
0000950170-23-009314.txt Edgar Link pending
0000950170-23-009314-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
img180293857_0.jpg Edgar Link pending
img180293857_1.jpg Edgar Link pending
img180293857_2.jpg Edgar Link pending
img208923008_0.jpg Edgar Link pending
img261712742_0.jpg Edgar Link pending
img261712742_1.jpg Edgar Link pending
img261712742_2.jpg Edgar Link pending
img261712742_3.jpg Edgar Link pending
img261712742_4.jpg Edgar Link pending
img261712742_5.jpg Edgar Link pending
img261712742_6.jpg Edgar Link pending
img261712742_7.jpg Edgar Link pending
img261712742_8.jpg Edgar Link pending
img261712742_9.jpg Edgar Link pending
img262636263_0.jpg Edgar Link pending
img262636263_1.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
mmat-20221231.htm Edgar Link pending
mmat-20221231.xsd Edgar Link pending
mmat-ex10_150.htm Edgar Link pending
mmat-ex10_50.htm Edgar Link pending
mmat-ex10_60.htm Edgar Link pending
mmat-ex21_10.htm Edgar Link pending
mmat-ex23_10.htm Edgar Link pending
mmat-ex2_30.htm Edgar Link pending
mmat-ex2_40.htm Edgar Link pending
mmat-ex2_50.htm Edgar Link pending
mmat-ex2_60.htm Edgar Link pending
mmat-ex2_70.htm Edgar Link pending
mmat-ex31_1.htm Edgar Link pending
mmat-ex31_2.htm Edgar Link pending
mmat-ex32_1.htm Edgar Link pending
mmat-ex32_2.htm Edgar Link pending
mmat-ex4_50.htm Edgar Link pending
mmat-ex4_51.htm Edgar Link pending
mmat-ex4_52.htm Edgar Link pending
mmat-ex4_60.htm Edgar Link pending
mmat-ex9_10.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R100.htm Edgar Link pending
R101.htm Edgar Link pending
R102.htm Edgar Link pending
R103.htm Edgar Link pending
R104.htm Edgar Link pending
R105.htm Edgar Link pending
mmat-20221231_lab.xml Edgar Link unprocessable
mmat-20221231_def.xml Edgar Link unprocessable
mmat-20221231_pre.xml Edgar Link unprocessable
mmat-20221231_htm.xml Edgar Link completed
R106.htm Edgar Link pending
R107.htm Edgar Link pending
R108.htm Edgar Link pending
R109.htm Edgar Link pending
R11.htm Edgar Link pending
R110.htm Edgar Link pending
R111.htm Edgar Link pending
R112.htm Edgar Link pending
R113.htm Edgar Link pending
R114.htm Edgar Link pending
R115.htm Edgar Link pending
R116.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
R94.htm Edgar Link pending
R95.htm Edgar Link pending
R96.htm Edgar Link pending
R97.htm Edgar Link pending
R98.htm Edgar Link pending
R99.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
mmat-20221231_cal.xml Edgar Link unprocessable